AGIO
AGIO
NASDAQ · Biotechnology

Agios Pharmaceuticals Inc

$29.60
+1.25 (+4.41%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 12 75%
Hold 4 25%
Sell 0 0%
Price Target
Analyst Price Target -63.3% upside
Low Target $8.41
Average Target $10.87
High Target $14.57
Current Price $29.60
Current
$29.60
Target
$10.87
$8.41 $10.87 avg $14.57
Scenario Analysis
Bear Case
$8.41
-71.6%
Low target
Base Case
$10.87
-63.3%
Avg target
Bull Case
$14.57
+-50.8%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$46.00
-35.7% from high
52-Week Low
$22.24
+33.1% from low
Target vs 52W High
$10.87
-76.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%